Your browser doesn't support javascript.
loading
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.
Jurado, Manuel; Vallejo, Carlos; Pérez-Simón, José A; Brunet, Salut; Ferra, Christelle; Balsalobre, Pascual; Pérez-Oteyza, Jaime; Espigado, Ildefonso; Romero, Antonio; Caballero, Dolores; Sierra, Jorge; Ribera, Jose M; Díez, Jose L.
Affiliation
  • Jurado M; Department of Hematology, Hospital Virgen de las Nieves, Granada, Spain. manuel.jurado.sspa@juntadeandalucia.es
Biol Blood Marrow Transplant ; 13(6): 701-6, 2007 Jun.
Article in En | MEDLINE | ID: mdl-17531780
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Sirolimus / Graft vs Host Disease Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2007 Document type: Article Affiliation country: Spain
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Sirolimus / Graft vs Host Disease Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2007 Document type: Article Affiliation country: Spain